socalTECH

FEBRUARY 24, 2014

San Diego-based venture investor Avalon Ventures has scored an exit this morning, after IBM said it has acquired Boston-based Cloudant , a developer of a NoSQL-based, cloud-based database. cloudant venture capital merger acquisition exit cloud software nosql database' in funding. in funding. READ MORE>>.

Avalon 173

Avalon IBM IBM San Diego 173

socalTECH

MARCH 15, 2012

San Diego-based Avalon Ventures , one of the venture capital investors in social gaming phenomenon Zynga , may be set to cash in on its shares of the newly public gaming firm, after Zynga said this week that it is planning a $400M, secondary offering of its stock.

Avalon 150

Avalon SoCal Southern California San Diego 150

socalTECH

JULY 16, 2013

In the latest positive move for the Los Angeles venture capital market, a new investor has moved into town, to take advantage of the area''s growing startup market. core innovation capital venture investment fund' READ MORE>>.

Capital 174

Capital Southern California Avalon SoCalTech 174

socalTECH

JULY 21, 2011

Amira Pharmaceuticals was venture backed by Avalon Ventures, Novo A/S,Prospect Venture Partners, and Versant Ventures. The firm had raised somewhere around $40M in venture capital funding. Bristol-Myers Squibb said it would pay $325M upfront, and up to $150M in milestone payments, for Amira.

Avalon 150

Avalon San Diego Venture Capital Capital 150

socalTECH

APRIL 1, 2013

The funding came from Divergent Ventures, along with existing investors Avalon Ventures. Bolt was most recently at Avamar Technologies, where he was CTO of the firm before its acquisition by EMC in 2006. The firm said the new funding brings its total raised to $5M. The firm is led by Rory Bolt. READ MORE>>.

Software 124

Software Avalon San Diego Design 124

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56